Press release
2019-2027 Orphan Drugs Market In-depth Analysis by Active Ingredients, Disease, Appication profiling CELGENE CORPORATION, Novartis AG, Takeda Pharmaceuticals, Biogen, Bristol-Myers Squibb
The Insight Partners
Orphan Drugs Market to 2027 - Global Analysis and Forecasts by Active ingredients (Obinutuzumab, Lenalidomide, Brentuximab, Vedotin, Riociguat, Ofatumumab, Nelarabine, Bosutinib, Mannitol, Carglumic acid, Aztreonam, Histamine hydrochloride, Eliglustat, Cabozantinib, Ramucirumab, Decitabine, Defibrotide) ; Disease (Hodgkin lymphoma, Paroxysmal nocturnal hemoglobinuria, Chronic thromboembolic pulmonary hypertension (CTEPH) , Chronic lymphocytic leukemia, Chronic Myeloid Leukaemia, T-cell acute lymphoblastic leukemia (T-ALL) , Philadelphia chromosome positive chronic myelogenous leukaemia (Ph+ CML) , Cystic fibrosis (CF) , acute myeloid leukaemia, Multiple Myeloma, Isovaleric acidaemia, Gaucher disease type 1 (GD1) , Metastatic medullary thyroid carcinoma, Advanced gastric cancer or gastro-esophageal junction adenocarcinoma, Secondary Acute myeloid leukemia (AML) , Severe hepatic venoocclusive disease (VOD) / sinusoidal obstructive syndrome (SOS) ) ; End User (Hospitals, Ambulatory Surgical Centers)
Orphan Drugs are pharmaceutical drugs that remain commercially undeveloped. These are vaccines, medicine or in-vivo diagnostic agent, which are intended to treat, diagnose and prevent a rare disease.
Get Sample Copy at https://www.theinsightpartners.com/sample/TIPRE00005799?utm_source=OpenPR&utm_medium=Simran
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Orphan Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Orphan Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Orphan Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Orphan Drugs market in these regions.
The report also includes the profiles of Orphan Drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Top Players covered in this Report are F. Hoffmann-La Roche, Eli Lilly and Company, Alexion, CELGENE CORPORATION, Novartis AG, Takeda Pharmaceuticals Company Limited, Biogen, Bristol-Myers Squibb Company, Bayer AG, Sanofi
Check Discount at https://www.theinsightpartners.com/discount/TIPRE00005799?utm_source=OpenPR&utm_medium=Simran
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Orphan Drugs Market - By Active ingredients
1.3.2 Orphan Drugs Market - By Disease
1.3.3 Orphan Drugs Market - By End User
1.3.4 Orphan Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ORPHAN DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ORPHAN DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
Buy this Report now at https://www.theinsightpartners.com/buy/TIPRE00005799?utm_source=OpenPR&utm_medium=Simran
Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com
About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2019-2027 Orphan Drugs Market In-depth Analysis by Active Ingredients, Disease, Appication profiling CELGENE CORPORATION, Novartis AG, Takeda Pharmaceuticals, Biogen, Bristol-Myers Squibb here
News-ID: 1795868 • Views: …
More Releases from The Insight Partners
Current Transformer Market is expected to grow a CAGR of 6.1% from 2025 to 2031
The Global Current Transformer Market 2031 that centers around Current Transformer Market examines the significant components with a top to bottom methodology and empowers the client to survey the drawn-out based interest additionally predicts explicit executions. This report gives subjective investigation, clarifying item scope and expounding Market experiences and standpoint.
To Get Sample Copy of Report, Click Here - https://www.theinsightpartners.com/sample/TIPRE00027549/?utm_source=OpenPR&utm_medium=10607
(Our SAMPLE COPY of the report offers a quick…
Healthy Eating Revolution Boosts Packaged Salad Dressings Market Growth Through …
New York, US - October 06, 2025 -The Packaged Salad Dressings market is entering a period of dynamic innovation and expansion, with consumers seeking healthier, flavorful, and convenient dressing options. The market is expected to register steady growth from 2025 to 2031, fueled by evolving consumer preferences and distribution innovations.
As more people globally adopt salads and healthy eating habits, demand for packaged dressings such as vinaigrette, ranch, balsamic, honey mustard,…
High Flow Oxygen Therapy Devices Market Size, Growth Status and Better Investmen …
The Insight Partners analysts forecasts the latest report on "Global High Flow Oxygen Therapy Devices Market (Covid-19) Impact and Analysis by 2031", according to report; The High Flow Oxygen Therapy Devices Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the High Flow Oxygen Therapy Devices…
Motor Protection Market Set for Robust Growth by 2031
The Insight Partners has published its latest research titled"Motor Protection Market Share, Size, Trends, and Forecast by 2031." The report projects consistent growth in the global motor protection market, fueled by increasing industrialization, advances in smart technologies, and tighter safety regulations. With growing infrastructure initiatives and the rise of intelligent systems, the market is poised for significant expansion in terms of size, market share, and innovation through 2031.
Check valuable insights…
More Releases for Orphan
Acquired Orphan Blood Disease Market
Acquired Orphan Blood Disease Market to reach over USD 18.93 billion by the year 2031 - Exclusive Report by InsightAce Analytic
According to a new report by InsightAce Analytic, the "Acquired Orphan Blood Disease Market" in terms of revenue was estimated to be worth $8.65 billion in 2023 and is poised to reach $18.93 billion by 2031, growing at a CAGR of 10.47% from 2024 to 2031.
Get Free Access to…
Orphan Drugs Market Size to Hit $3199.3 Billion by 2028 | Orphan Drugs Industry …
Market Overview:
According to our experience research team, Orphan Drugs Market was valued at USD 112.36 Billion in 2021, and the global Orphan Drugs industry is projected to reach a value of USD 3199.3 Billion by 2028, at a CAGR of 7.4% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy &…
Orphan Drugs for Cancer Pipeline Analysis
A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed…
US Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.…
Europe Orphan Drugs Pipeline Analysis
“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug…
Global Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the…
